Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Fine needle aspiration of malignant melanoma with myxoid features: A case report with molecular analysis.

Felty CC, Jackson CR, Marotti JD, Liu X.

Diagn Cytopathol. 2019 Dec 24. doi: 10.1002/dc.24376. [Epub ahead of print]

PMID:
31872974
2.

Calcifications mimicking ductal carcinoma in situ in a patient with end-stage renal disease.

Shee K, Veilleux LW, Linos K, Marotti JD.

Breast J. 2019 Sep;25(5):989-990. doi: 10.1111/tbj.13392. Epub 2019 Jun 6. No abstract available.

PMID:
31172604
3.

Hemosiderin-laden mesothelial cells in a pericardial effusion.

Marotti JD, Gutmann EJ.

Diagn Cytopathol. 2019 Sep;47(9):963-965. doi: 10.1002/dc.24209. Epub 2019 May 29. No abstract available.

PMID:
31140733
4.

Papillary and sclerosing lesions of the breast detected and biopsied by MRI: Clinical management, upgrade rate, and association with apocrine metaplasia.

Ring NY, diFlorio-Alexander RM, Bond JS, Rosenkranz KM, Cervantes E, Sohn JH, Marotti JD.

Breast J. 2019 May;25(3):393-400. doi: 10.1111/tbj.13238. Epub 2019 Apr 3.

PMID:
30945398
5.

Pathologic Features and Clinical Implications of Breast Cancer With HER2 Intratumoral Genetic Heterogeneity.

Muller KE, Marotti JD, Tafe LJ.

Am J Clin Pathol. 2019 Jun 5;152(1):7-16. doi: 10.1093/ajcp/aqz010.

PMID:
30892594
6.

Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.

Chen Y, Wang Y, Salas LA, Miller TW, Mark K, Marotti JD, Kettenbach AN, Cheng C, Christensen BC.

Breast Cancer Res. 2019 Jan 25;21(1):14. doi: 10.1186/s13058-018-1090-z.

7.

The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.

Arias-Pulido H, Cimino-Mathews A, Chaher N, Qualls C, Joste N, Colpaert C, Marotti JD, Foisey M, Prossnitz ER, Emens LA, Fiering S.

Breast Cancer Res Treat. 2018 Sep;171(2):273-282. doi: 10.1007/s10549-018-4834-7. Epub 2018 Jun 1.

8.

Cokeromyces recurvatus in a Papanicolaou test: An exceedingly rare finding that can be mistaken for Paracoccidioides brasiliensis.

Sharma N, Schwartzman JD, Gutmann EJ, Marotti JD, Liu X.

Cytojournal. 2018 Feb 16;15:5. doi: 10.4103/cytojournal.cytojournal_35_17. eCollection 2018.

9.

Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer.

Yang W, Schwartz GN, Marotti JD, Chen V, Traphagen NA, Gui J, Miller TW.

Oncotarget. 2018 Jan 15;9(10):8810-8822. doi: 10.18632/oncotarget.24256. eCollection 2018 Feb 6.

10.

Genotype-Phenotype Correlations in Breast Cancer.

Marotti JD, Schnitt SJ.

Surg Pathol Clin. 2018 Mar;11(1):199-211. doi: 10.1016/j.path.2017.09.008. Epub 2017 Dec 15. Review.

PMID:
29413657
11.

Indeterminate diagnoses in EUS-guided FNA of the pancreas: analysis of cytologist and clinician perceptions, cytologic features, and clinical outcomes.

Olofson AM, Biernacka A, Li Z, Boonipat T, Gutmann EJ, Smith KD, Gardner TB, Gordon SR, Padmanabhan V, Marotti JD, Liu X.

J Am Soc Cytopathol. 2018 Sep - Oct;7(5):274-281. doi: 10.1016/j.jasc.2018.02.006. Epub 2018 Mar 1.

PMID:
31043287
12.

Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer.

Nutter EL, Weiss JE, Marotti JD, Barth RJ Jr, Eliassen MS, Goodrich ME, Petersen CL, Onega T.

Cancer. 2018 Apr 1;124(7):1350-1357. doi: 10.1002/cncr.31202. Epub 2017 Dec 20.

13.

A Patient-Specific 3D-Printed Form Accurately Transfers Supine MRI-Derived Tumor Localization Information to Guide Breast-Conserving Surgery.

Barth RJ Jr, Krishnaswamy V, Paulsen KD, Rooney TB, Wells WA, Rizzo E, Angeles CV, Marotti JD, Zuurbier RA, Black CC.

Ann Surg Oncol. 2017 Oct;24(10):2950-2956. doi: 10.1245/s10434-017-5979-z. Epub 2017 Aug 1.

14.

Triple-Negative Breast Cancer: Next-Generation Sequencing for Target Identification.

Marotti JD, de Abreu FB, Wells WA, Tsongalis GJ.

Am J Pathol. 2017 Oct;187(10):2133-2138. doi: 10.1016/j.ajpath.2017.05.018. Epub 2017 Jul 20. Review.

15.

Concordance of DNA methylation profiles between breast core biopsy and surgical excision specimens containing ductal carcinoma in situ (DCIS).

Chen Y, Marotti JD, Jenson EG, Onega TL, Johnson KC, Christensen BC.

Exp Mol Pathol. 2017 Aug;103(1):78-83. doi: 10.1016/j.yexmp.2017.07.001. Epub 2017 Jul 12.

16.

P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic Site.

Marotti JD, Muller KE, Tafe LJ, Demidenko E, Miller TW.

Int J Breast Cancer. 2017;2017:4537532. doi: 10.1155/2017/4537532. Epub 2017 Jun 15.

17.

IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.

Chiang S, Weigelt B, Wen HC, Pareja F, Raghavendra A, Martelotto LG, Burke KA, Basili T, Li A, Geyer FC, Piscuoglio S, Ng CK, Jungbluth AA, Balss J, Pusch S, Baker GM, Cole KS, von Deimling A, Batten JM, Marotti JD, Soh HC, McCalip BL, Serrano J, Lim RS, Siziopikou KP, Lu S, Liu X, Hammour T, Brogi E, Snuderl M, Iafrate AJ, Reis-Filho JS, Schnitt SJ.

Cancer Res. 2016 Dec 15;76(24):7118-7129. Epub 2016 Oct 20.

18.

Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer.

Sheen MR, Marotti JD, Allegrezza MJ, Rutkowski M, Conejo-Garcia JR, Fiering S.

Oncogenesis. 2016 Oct 31;5(10):e267. doi: 10.1038/oncsis.2016.65.

19.

Clinical Genotyping of Non-Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes.

Tafe LJ, Pierce KJ, Peterson JD, de Abreu F, Memoli VA, Black CC, Pettus JR, Marotti JD, Gutmann EJ, Liu X, Shirai K, Dragnev KH, Amos CI, Tsongalis GJ.

Neoplasia. 2016 Sep;18(9):577-83. doi: 10.1016/j.neo.2016.07.010.

20.

Somatic gene mutation analysis of triple negative breast cancers.

Dillon JL, Mockus SM, Ananda G, Spotlow V, Wells WA, Tsongalis GJ, Marotti JD.

Breast. 2016 Oct;29:202-7. doi: 10.1016/j.breast.2016.06.018. Epub 2016 Jul 7.

PMID:
27397723
21.

Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.

Muller KE, Marotti JD, de Abreu FB, Peterson JD, Miller TW, Chamberlin MD, Tsongalis GJ, Tafe LJ.

Exp Mol Pathol. 2016 Jun;100(3):421-5. doi: 10.1016/j.yexmp.2016.04.002. Epub 2016 Apr 16.

PMID:
27095739
22.

Proliferative lesion of anogenital mammary-like glands in the setting of Cowden syndrome: case report and review of the literature.

Hedayat AA, Pettus JR, Marotti JD, Tafe LJ, Holubar SD, Lisovsky M.

J Cutan Pathol. 2016 Aug;43(8):707-10. doi: 10.1111/cup.12721. Epub 2016 May 9. Review.

PMID:
27090873
23.

Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer.

Yang W, Hosford SR, Dillon LM, Shee K, Liu SC, Bean JR, Salphati L, Pang J, Zhang X, Nannini MA, Demidenko E, Bates D, Lewis LD, Marotti JD, Eastman AR, Miller TW.

Clin Cancer Res. 2016 May 1;22(9):2250-60. doi: 10.1158/1078-0432.CCR-15-2276. Epub 2016 Jan 5.

24.

DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.

Johnson KC, Koestler DC, Fleischer T, Chen P, Jenson EG, Marotti JD, Onega T, Kristensen VN, Christensen BC.

Clin Epigenetics. 2015 Jul 25;7:75. doi: 10.1186/s13148-015-0094-0. eCollection 2015.

25.

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

Tafe LJ, Gorlov IP, de Abreu FB, Lefferts JA, Liu X, Pettus JR, Marotti JD, Bloch KJ, Memoli VA, Suriawinata AA, Dragnev KH, Fadul CE, Schwartz GN, Morgan CR, Holderness BM, Peterson JD, Tsongalis GJ, Miller TW, Chamberlin MD.

Oncologist. 2015 Sep;20(9):1011-8. doi: 10.1634/theoncologist.2015-0097. Epub 2015 Jul 23.

26.
27.

Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.

Collins LC, Gelber S, Marotti JD, White S, Ruddy K, Brachtel EF, Schapira L, Come SE, Borges VF, Schedin P, Warner E, Wensley T, Tamimi RM, Winer EP, Partridge AH.

Oncologist. 2015 Jul;20(7):713-8. doi: 10.1634/theoncologist.2014-0412. Epub 2015 May 29.

28.

Glioblastoma multiforme with epithelial differentiation: a potential diagnostic pitfall in cerebrospinal fluid cytology.

Gill SK, Padmanabhan V, Hickey WF, Marotti JD.

Diagn Cytopathol. 2015 Aug;43(8):638-41. doi: 10.1002/dc.23274. Epub 2015 Apr 23.

PMID:
25913842
29.

Cytologic rapid on-site evaluation of transthoracic computed tomography-guided lung needle biopsies: who should perform ROSE? A cross-institutional analysis of procedural and diagnostic outcomes.

Marotti JD, Rao KP, Brister KJ, Gutmann EJ, Tsapakos MJ, Sheiman R, Wang HH, VanderLaan PA.

J Am Soc Cytopathol. 2015 May - Jun;4(3):160-169. doi: 10.1016/j.jasc.2015.01.004. Epub 2015 Jan 14.

PMID:
31051697
30.

Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.

diFlorio-Alexander RM, Marotti JD, Bond JS, Schwab MC, Memoli VA, Wells WA, Poplack SP.

AJR Am J Roentgenol. 2015 Jan;204(1):211-8. doi: 10.2214/AJR.14.12869.

PMID:
25539259
31.

The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.

Bean JR, Hosford SR, Symonds LK, Owens P, Dillon LM, Yang W, Shee K, Schwartz GN, Marotti JD, Muller KE, Rosenkranz KM, Barth RJ, Chen VS, Agarwal VR, Miller TW.

Breast Cancer Res Treat. 2015 Jan;149(1):69-79. doi: 10.1007/s10549-014-3201-6. Epub 2014 Dec 10.

32.

Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma.

Muller KE, Tafe LJ, de Abreu FB, Peterson JD, Wells WA, Barth RJ, Marotti JD.

Hum Pathol. 2015 Feb;46(2):327-33. doi: 10.1016/j.humpath.2014.10.014. Epub 2014 Nov 4.

PMID:
25476122
33.

Automated processing of fluorescence in-situ hybridization slides for HER2 testing in breast and gastro-esophageal carcinomas.

Tafe LJ, Allen SF, Steinmetz HB, Dokus BA, Cook LJ, Marotti JD, Tsongalis GJ.

Exp Mol Pathol. 2014 Aug;97(1):116-9. doi: 10.1016/j.yexmp.2014.06.003. Epub 2014 Jun 11.

PMID:
24927872
34.

Implementation of telecytology for immediate assessment of endoscopic ultrasound-guided fine-needle aspirations compared to conventional on-site evaluation: analysis of 240 consecutive cases.

Marotti JD, Johncox V, Ng D, Gonzalez JL, Padmanabhan V.

Acta Cytol. 2012;56(5):548-53. doi: 10.1159/000339546. Epub 2012 Sep 27.

PMID:
23075898
35.

Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.

Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH.

Breast Cancer Res Treat. 2012 Feb;131(3):1061-6. doi: 10.1007/s10549-011-1872-9. Epub 2011 Nov 13.

PMID:
22080245
36.

Presence of benign germ cells in a fine needle aspirate of a spermatocele.

Marotti JD, Seigne JD, Gutmann EJ.

Diagn Cytopathol. 2013 Apr;41(4):342-3. doi: 10.1002/dc.21846. Epub 2011 Nov 1. No abstract available.

PMID:
22045691
37.

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases.

Marotti JD, Schwab MC, McNulty NJ, Rigas JR, DeLong PA, Memoli VA, Tsongalis GJ, Padmanabhan V.

Diagn Cytopathol. 2013 Jan;41(1):15-21. doi: 10.1002/dc.21749. Epub 2011 Jun 16.

PMID:
21681971
38.

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM.

Mod Pathol. 2011 Jul;24(7):924-31. doi: 10.1038/modpathol.2011.54. Epub 2011 May 6.

39.

International Internet-based assessment of observer variability for diagnostically challenging endometrial biopsies.

Marotti JD, Glatz K, Parkash V, Hecht JL.

Arch Pathol Lab Med. 2011 Apr;135(4):464-70. doi: 10.1043/2010-0139-OA.1.

PMID:
21466363
40.

Androgen receptor expression and breast cancer survival in postmenopausal women.

Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA, Tamimi RM.

Clin Cancer Res. 2011 Apr 1;17(7):1867-74. doi: 10.1158/1078-0432.CCR-10-2021. Epub 2011 Feb 15.

41.

Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

Marotti JD, Collins LC, Hu R, Tamimi RM.

Mod Pathol. 2010 Feb;23(2):197-204. doi: 10.1038/modpathol.2009.158. Epub 2009 Nov 6.

42.

Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor alpha expression in ovarian tumors.

Kotsopoulos J, Hecht JL, Marotti JD, Kelemen LE, Tworoger SS.

Int J Cancer. 2010 May 1;126(9):2191-8. doi: 10.1002/ijc.24723.

43.

Comparison of estrogen receptor results from pathology reports with results from central laboratory testing.

Collins LC, Marotti JD, Baer HJ, Tamimi RM.

J Natl Cancer Inst. 2008 Feb 6;100(3):218-21. doi: 10.1093/jnci/djm270. Epub 2008 Jan 29.

44.

Cerebral amyloid angiitis processing to generalized angiitis and leucoencephalitis.

Marotti JD, Savitz SI, Kim WK, Williams K, Caplan LR, Joseph JT.

Neuropathol Appl Neurobiol. 2007 Aug;33(4):475-9. Epub 2007 Jun 15. No abstract available.

PMID:
17573809
45.

Acute monocular blindness resulting from transformation of von Recklinghausen's neurofibromatosis to malignant melanocytic schwannomas.

Wrzesinski SH, Dragnev KH, Mayo LK, Harris BT, Marotti JD.

J Neurooncol. 2006 Feb;76(3):277-81.

PMID:
16244794
46.

Adult onset leukodystrophy with neuroaxonal spheroids and pigmented glia: report of a family, historical perspective, and review of the literature.

Marotti JD, Tobias S, Fratkin JD, Powers JM, Rhodes CH.

Acta Neuropathol. 2004 Jun;107(6):481-8. Epub 2004 Apr 6.

PMID:
15067553

Supplemental Content

Loading ...
Support Center